Sabra Health Care REIT, Inc. (SBRA) stock
SBRANasdaqReal Estate Investment TrustsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 6/3059% above fair value
$20.62+0.37 (+1.83%)
Close on Nov 18, 2026Market cap $5.27BP/E 79.3Yield 5.82%
Sabra Health Care REIT revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Sabra Health Care REIT's revenue for the twelve months ending Jun 30, 2026 was $859.56M, up 17.3% year over year. For fiscal 2025 it was $774.63M, up 10.2% from the year before. Over ten years it grew 12.5% a year on average. The highest annual figure on record is $774.63M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $774.63M | +10.2% |
| FY2024 | Dec 31, 2024 | $703.24M | +8.6% |
| FY2023 | Dec 31, 2023 | $647.51M | +3.6% |
| FY2022 | Dec 31, 2022 | $624.81M | +9.7% |
| FY2021 | Dec 31, 2021 | $569.55M | -4.8% |
| FY2020 | Dec 31, 2020 | $598.57M | -9.5% |
| FY2019 | Dec 31, 2019 | $661.74M | +6.1% |
| FY2018 | Dec 31, 2018 | $623.41M | +52.7% |
| FY2017 | Dec 31, 2017 | $408.28M | +56.7% |
| FY2016 | Dec 31, 2016 | $260.53M | +9.1% |
| FY2015 | Dec 31, 2015 | $238.86M | +30.2% |
| FY2014 | Dec 31, 2014 | $183.52M | +36.2% |
| FY2013 | Dec 31, 2013 | $134.78M | +30.6% |
| FY2012 | Dec 31, 2012 | $103.17M | +22.5% |
| FY2011 | Dec 31, 2011 | $84.23M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $235.87M | +24.7% |
| Q1 FY2026 | Mar 31, 2026 | $221.75M | +20.8% |
| Q4 FY2025 | Dec 31, 2025 | $211.90M | +16.2% |
| Q3 FY2025 | Sep 30, 2025 | $190.04M | +6.8% |
| Q2 FY2025 | Jun 30, 2025 | $189.15M | +7.4% |
| Q1 FY2025 | Mar 31, 2025 | $183.54M | +10.1% |
| Q4 FY2024 | Dec 31, 2024 | $182.35M | +11.6% |
| Q3 FY2024 | Sep 30, 2024 | $178.00M | +10.1% |
| Q2 FY2024 | Jun 30, 2024 | $176.14M | +9.3% |
| Q1 FY2024 | Mar 31, 2024 | $166.75M | +3.4% |
| Q4 FY2023 | Dec 31, 2023 | $163.40M | -1.0% |
| Q3 FY2023 | Sep 30, 2023 | $161.63M | +14.8% |
| Q2 FY2023 | Jun 30, 2023 | $161.17M | +3.3% |
| Q1 FY2023 | Mar 31, 2023 | $161.32M | -1.1% |
| Q4 FY2022 | Dec 31, 2022 | $164.99M | +21.6% |
| Q3 FY2022 | Sep 30, 2022 | $140.76M | +9.5% |
| Q2 FY2022 | Jun 30, 2022 | $155.96M | +2.0% |
| Q1 FY2022 | Mar 31, 2022 | $163.11M | +7.0% |
| Q4 FY2021 | Dec 31, 2021 | $135.66M | -10.8% |
| Q3 FY2021 | Sep 30, 2021 | $128.59M | -10.2% |
| Q2 FY2021 | Jun 30, 2021 | $152.93M | -0.6% |
| Q1 FY2021 | Mar 31, 2021 | $152.37M | +2.0% |
| Q4 FY2020 | Dec 31, 2020 | $152.05M | -2.4% |
| Q3 FY2020 | Sep 30, 2020 | $143.25M | -4.4% |
| Q2 FY2020 | Jun 30, 2020 | $153.92M | -29.8% |
| Q1 FY2020 | Mar 31, 2020 | $149.35M | +9.2% |
| Q4 FY2019 | Dec 31, 2019 | $155.76M | +11.9% |
| Q3 FY2019 | Sep 30, 2019 | $149.83M | -1.3% |
| Q2 FY2019 | Jun 30, 2019 | $219.37M | +31.9% |
| Q1 FY2019 | Mar 31, 2019 | $136.77M | -17.6% |
| Q4 FY2018 | Dec 31, 2018 | $139.21M | -17.7% |
| Q3 FY2018 | Sep 30, 2018 | $151.80M | +35.8% |
| Q2 FY2018 | Jun 30, 2018 | $166.31M | +156.9% |
| Q1 FY2018 | Mar 31, 2018 | $166.09M | +165.1% |
| Q4 FY2017 | Dec 31, 2017 | $169.11M | +173.7% |
| Q3 FY2017 | Sep 30, 2017 | $111.79M | +80.5% |
| Q2 FY2017 | Jun 30, 2017 | $64.74M | – |
| Q1 FY2017 | Mar 31, 2017 | $62.65M | – |
| Q4 FY2016 | Dec 31, 2016 | $61.79M | – |
| Q3 FY2016 | Sep 30, 2016 | $61.93M | – |
See a number that looks wrong?